0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Anne Marie McCarthy, ScM, PhD; Katrina Armstrong, MD, MSCE
JAMA Intern Med. 2014;174(7):1023-1024. doi:10.1001/jamainternmed.2014.1322.

Invited Commentary | 
Victor Grann, MD, MPH; Maxine Ashby-Thompson, MPH
JAMA Intern Med. 2013;173(2):103-104. doi:10.1001/jamainternmed.2013.2729.

Research Letters |  FREE
Analía R. Stormo, BS; Nikki A. Hawkins, PhD; Crystale Purvis Cooper, PhD; et al.
Arch Intern Med. 2011;171(22):2053-2054. doi:10.1001/archinternmed.2011.575.

Original Investigation |  FREE
Susanna C. Larsson, MSc; Alicja Wolk, DMSc
Arch Intern Med. 2005;165(22):2683-2686. doi:10.1001/archinte.165.22.2683.

Original Investigation |  FREE
Eva Glud, MD, PhD; Susanne K. Kjaer, DMSc; Birthe L. Thomsen, MSc; et al.
Arch Intern Med. 2004;164(20):2253-2259. doi:10.1001/archinte.164.20.2253.

Editor's Correspondence | 
John Hausdorff, MD; John Bennetts, MD; Ron Fuerstner, MD
Arch Intern Med. 1999;159(16):1954. doi:.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Internal Medicine Collections
From The JAMA Network
JAMA Oncology
Viewpoint  | 
Cost-effectiveness of Universal BRCA1/2 Screening Evidence-Based Decision Making
Elisa F. Long, PhD; Patricia A. Ganz, MD
JAMA Oncology
Invited Commentary  | 
Usefulness of Multigene Testing Catching the Train That’s Left the Station
Elizabeth M. Swisher, MD
JAMA Oncology
Original Investigation  | 
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Oncology
Editorial  | 
Ovarian Cancer Survival and Chemotherapy Dosing, Body Mass Index, and Body Surface Area  Are We There Yet?
S. Percy Ivy, MD; Jan H. Beumer, PharmD, PhD